PH1
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Exploratory Study of YOLT-203 in Patients With Primary Hyperoxaluria Type 1 (PH1) (NCT07776626) | YolTech Therapeutics Co., Ltd | 2026-08-01 |
| Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1) (NCT07587021) | YolTech Therapeutics Co., Ltd | 2026-08-01 |
| An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1 (NCT03350451) | Alnylam Pharmaceuticals | 2018-04-04 |
Track PH1 automatically
Every clearance here is in the API, with alerts when new ones post.